Events2Join

Clinical application of liquid biopsy based on circulating tumor DNA ...


Clinical application of liquid biopsy based on circulating tumor DNA ...

In this review, we assess the role of ctDNA testing in the diagnosis and management of NSCLC as a reference for clinical intervention in this disease.

Clinical application of liquid biopsy based on circulating tumor DNA ...

ctDNA serves as a credible “liquid biopsy” diagnostic tool that, to a certain extent, overcomes tumor heterogeneity and harbors genetic ...

Clinical Application of Liquid Biopsy-Based Circulating Tumor DNA ...

The use of liquid biopsies for postoperative screening in breast cancer survivors has been explored as a safer and easier alternative.

Liquid biopsy: current technology and clinical applications

Circulating extracellular nucleic acids (cell-free DNA; cfDNA), circulating tumor DNA (ctDNA), and circulating tumor cells (CTCs) can be ...

Liquid biopsy: from concept to clinical application | Scientific Reports

Liquid biopsies can be used to access tumor cells and tumor DNA circulating in the blood. Monitoring these species can provide a minimally invasive and ...

Liquid biopsy into the clinics: Current evidence and future perspectives

These biopsies involve most commonly the isolation of circulating extracellular nucleic acids, including cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) ...

Clinical Applications of Circulating Tumor Cells ... - AACR Journals

“Liquid biopsy” focusing on the analysis of circulating tumor cells (CTC) and circulating cell-free tumor DNA (ctDNA) in the blood of patients with cancer ...

Liquid biopsy: Comprehensive overview of circulating tumor DNA ...

Liquid biopsy techniques primarily involve detection of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA).

Clinical Applications of Circulating Tumour Cells and ... - Frontiers

Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) are two main derivatives of liquid biopsy. CTC enumeration and molecular analysis enable ...

Clinical application of liquid biopsy in colorectal cancer: detection ...

Analysis of circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), or tumor-associated platelets (TEPs) in the blood can be used for ...

How liquid biopsies can change clinical practice in oncology

The analysis of circulating tumor DNA (ctDNA), commonly known as liquid biopsy, can be exploited for a variety of clinical applications. ctDNA is being used to ...

Liquid Biopsies: Emerging role and clinical applications in solid ...

ctDNA-based liquid biopsy is an another tool for molecular diagnosis and surveillance of cancer [21]. Once released from tumour cells, ctDNA harboring original ...

Circulating tumor DNA: from discovery to clinical application in ...

ctDNA-based approaches can effectively compensate for the shortcomings of traditional screening and monitoring methods, which fail to provide ...

Diagnostic value of liquid biopsy in the era of precision medicine

Among these, the circulating tumor DNA (ctDNA) has emerged as a promising biomarker in the liquid biopsy test for clinical needs. In this review, the current ...

Using Circulating Tumor DNA in Colorectal Cancer: Current and ...

In newly diagnosed metastatic colorectal cancer, liquid biopsy (blood-based next-generation sequencing) testing can provide the relevant ...

Current and future applications of liquid biopsy in non-small-cell ...

In metastatic NSCLC, ctDNA testing already plays a vital role in clinical practice, allowing the detection of tumor-derived somatic aberrations from plasma to ...

Clinical Applications of Liquid Biopsy in Prostate Cancer - MDPI

Section summary: Changes in CTCs and ctDNA have well-established prognostic implications independent of PSA changes and are used as markers of response in ...

Liquid Biopsy: What It Is & Procedure Details - Cleveland Clinic

Circulating tumor cells (CTCs): A CTC is a cancer cell from the tumor that's traveling in your bloodstream. · Circulating tumor DNA (ctDNA): ...

Circulating tumor DNA: a promising biomarker in the liquid biopsy of ...

Recent advances in our understanding of the biology and clinical application of ctDNA have provided evidence that the use of ctDNA as a liquid ...

Liquid Biopsy: Using Tumor DNA in Blood to Aid Cancer Care - NCI

One potential application of ctDNA-based liquid biopsies is for detecting cancer at an early stage, when treatment may be most successful. In ...